Delivery Order SPE2DB20D7059-SPE2DB25FQME3
- Not listed
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $4,690.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5ML) with a completion date of September 3, 2025. The contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $33.5K delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) under a firm fixed-price contract with a completion date of September 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical and medical supply vendor for federal healthcare procurement. The order was placed to the company's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5ML) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a routine pharmaceutical procurement through the federal medical supply chain, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $15,084.90 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on May 14, 2025, with completion scheduled for May 15, 2025. This non-set-aside contract employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under AmerisourceBergen's existing federal contract framework with the Defense Logistics...
- The Defense Logistics Agency awarded a $1,358.05 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adacel TDAP vaccine in 0.5 mL vials. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,670.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded on July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that maintains an extensive portfolio of products...
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQME3Delivery Order
The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that provides medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad portfolio of pharmaceutical products and medical supplies to defense and healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting demonstrates capability across multiple therapeutic domains and product categories, from vaccines and specialty medications to medical devices and test kits. The Adacel TDAP vaccine syringes procured under this order support military medical readiness and immunization programs. All of AmerisourceBergen's reviewed contract awards have been competitively awarded with firm fixed pricing, demonstrating its ability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |